|
Ultravist 300 mg I/ml sol inj 10x100 ml (fľ.skl.)
300 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 300 mg I/ml sol inj 10x20 ml (fľ.skl.)
300 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 300 mg I/ml sol inj 10x50 ml (fľ.skl.)
300 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 300 mg I/ml sol inj 1x100 ml (fľ.skl.)
300 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 300 mg I/ml sol inj 1x50 ml (fľ.skl.)
300 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 370 mg I/ml sol inj 10x100 ml (fľ.skl.)
370 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 370 mg I/ml sol inj 10x200 ml (fľ.skl.)
370 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 370 mg I/ml sol inj 10x50 ml (fľ.skl.)
370 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 370 mg I/ml sol inj 1x100 ml (fľ.skl.)
370 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 370 mg I/ml sol inj 1x200 ml (fľ.skl.)
370 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 370 mg I/ml sol inj 1x50 ml (fľ.skl.)
370 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
Ultravist 370 mg I/ml sol inj 1x500 ml (fľ.skl.)
370 mg/1 ml
|
Injekčný roztok |
V08AB05
|
Bayer AG |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x10 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x100 ml (fľ.inf.skl.)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x100 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x150 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x175 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x20 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x20 ml (liek.inj.skl.)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x200 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x40 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x50 ml (fľ.inf.skl.)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x50 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|
|
VISIPAQUE 270 mg I/1 ml sol inj 10x75 ml (fľ.PP)
270 mg I/ ml
|
Injekčný roztok |
V08AB09
|
GE Healthcare AS |
—
|